Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Tests a pressure device with rehabilitation in people recovering from stroke

Tests a leg-pressure device added to standard rehabilitation in adults after stroke.

Plain-language title generated from the registry record
Registry title: Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Key facts

Where
Taichung, TaiwanSee the site

Where in Taiwan

  • China Medical University Hospital Taichung East District BranchTaichung, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
China Medical University Hospital
Trial code
NCT06711003
Record updated
2 December 2024
Original description
The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are:Read full original descriptionShow less

Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are:

What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.

Inclusion: Patients with acute cerebrovascular disease, within 1 month after acute attack; Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment; Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans; Aged over 20 years old.

Exclusion: The presence of documented aortic aneurysm/dissection requiring surgical repair; Patients with atrial fibrillation/arrhythmia; Within 2 weeks after cardiac catheterization or arterial puncture at the femoral artery puncture site; Decompensated heart failure (NYHA class 3 or 4); Persistent and uncontrolled hypertension (blood pressure persistently >160/100 mmHg); Bleeding tendency; Active phlebitis/venous disease of the lower extremities; Severe vascular occlusive disease of the lower extremities; Left ventricular ejection fraction (EF) < 30%; Moderate or severe aortic regurgitation; Pregnancy.

ClinicalTrials.gov NCT06711003